Canopus Biopharma Inc (CBIA)

[BigBadWolf]

However any shares sold from a Reg A offering have no restrictions under Rule 144.

Yes, the securities sold in a Regulation A+ offering are not considered “restricted securities” under Securities Act Rule 144. As a result, sales of securities by persons who are not affiliates of the issuer are not subject to any transfer restrictions under Rule 144

Regulation A is an exemption from registration for public offerings. Regulation A has two offering tiers: Tier 1, for offerings of up to $20 million in a 12-month period; and Tier 2, for offerings of up to $75 million in a 12-month period.

Annual Offering Limits $20 million, including no more than $6 million on behalf of selling securityholders that are affiliates of the issuer. $50 million, including no more than $15 million on behalf of selling securityholders that are affiliates of the issuer. Preemption of State Securities Laws No preemption.